Carregant...
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Diabetic retinopathy is the leading cause of blindness in working age adults, and is projected to be a significant future health concern due to the rising incidence of diabetes. The recent advent of anti-vascular endothelial growth factor (VEGF) antibodies has revolutionized the treatment of diabeti...
Guardat en:
| Publicat a: | Int J Mol Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037775/ https://ncbi.nlm.nih.gov/pubmed/27618014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17091498 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|